Literature DB >> 26984355

Biomarkers of hypoxia, endothelial and circulatory dysfunction among climbers in Nepal with AMS and HAPE: a prospective case-control study.

Kevin R Barker1, Andrea L Conroy2, Michael Hawkes3, Holly Murphy4, Prativa Pandey4, Kevin C Kain5.   

Abstract

BACKGROUND: The mechanisms underlying acute mountain sickness (AMS) and high-altitude pulmonary edema (HAPE) are not fully understood. We hypothesized that regulators of endothelial function, circulatory homeostasis, hypoxia and cell stress contribute to the pathobiology of AMS and HAPE.
METHODS: We conducted a prospective case-control study of climbers developing altitude illness who were evacuated to the CIWEC clinic in Kathmandu, compared to healthy acclimatized climbers. ELISA was used to measure plasma biomarkers of the above pathways.
RESULTS: Of the 175 participants, there were 71 cases of HAPE, 54 cases of AMS and 50 acclimatized controls (ACs). Markers of endothelial function were associated with HAPE: circulating levels of endothelin-1 (ET-1) were significantly elevated and levels of sKDR (soluble kinase domain receptor) were significantly decreased in cases of HAPE compared to AC or AMS. ET-1 levels were associated with disease severity as indicated by oxygen saturation. Angiopoietin-like 4 (Angptl4) and resistin, a marker of cell stress, were associated with AMS and HAPE irrespective of severity. Corin and angiotensin converting enzyme, regulators of volume homeostasis, were significantly decreased in HAPE compared to AC.
CONCLUSION: Our findings indicate that regulators of endothelial function, vascular tone and cell stress are altered in altitude illness and may mechanistically contribute to the pathobiology of HAPE. © International Society of Travel Medicine, 2016. All rights reserved. Published by Oxford University Press. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Acute mountain sickness; altitude illness; circulatory homeostasis; endothelial dysfunction; endothelin-1; high-altitude pulmonary edema; hypoxia

Mesh:

Substances:

Year:  2016        PMID: 26984355      PMCID: PMC5731443          DOI: 10.1093/jtm/taw005

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  67 in total

Review 1.  Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy.

Authors:  Yuichi Oike; Masaki Akao; Yoshiaki Kubota; Toshio Suda
Journal:  Trends Mol Med       Date:  2005-09-08       Impact factor: 11.951

Review 2.  Regulation of Weibel-Palade body exocytosis.

Authors:  Charles J Lowenstein; Craig N Morrell; Munekazu Yamakuchi
Journal:  Trends Cardiovasc Med       Date:  2005-11       Impact factor: 6.677

Review 3.  Endothelial activation, dysfunction and permeability during severe infections.

Authors:  Warren L Lee; W Conrad Liles
Journal:  Curr Opin Hematol       Date:  2011-05       Impact factor: 3.284

4.  Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high-altitude pulmonary edema.

Authors:  T Busch; P Bärtsch; D Pappert; E Grünig; W Hildebrandt; H Elser; K J Falke; E R Swenson
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

Review 5.  New insights in the pathogenesis of high-altitude pulmonary edema.

Authors:  Urs Scherrer; Emrush Rexhaj; Pierre-Yves Jayet; Yves Allemann; Claudio Sartori
Journal:  Prog Cardiovasc Dis       Date:  2010 May-Jun       Impact factor: 8.194

6.  Decreased pulmonary vascular resistance during nasal breathing: modulation by endogenous nitric oxide from the paranasal sinuses.

Authors:  G Settergren; M Angdin; R Astudillo; S Gelinder; J Liska; J O Lundberg; E Weitzberg
Journal:  Acta Physiol Scand       Date:  1998-07

7.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

Authors:  B Millauer; S Wizigmann-Voos; H Schnürch; R Martinez; N P Møller; W Risau; A Ullrich
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

8.  BDNF secretion by human pulmonary artery endothelial cells in response to hypoxia.

Authors:  Martin Helan; Bharathi Aravamudan; William R Hartman; Michael A Thompson; Bruce D Johnson; Christina M Pabelick; Y S Prakash
Journal:  J Mol Cell Cardiol       Date:  2014-01-23       Impact factor: 5.000

9.  VDR attenuates acute lung injury by blocking Ang-2-Tie-2 pathway and renin-angiotensin system.

Authors:  Juan Kong; Xiangdong Zhu; Yongyan Shi; Tianjing Liu; Yunzi Chen; Ishir Bhan; Qun Zhao; Ravi Thadhani; Yan Chun Li
Journal:  Mol Endocrinol       Date:  2013-11-06

10.  Differences in vascular effects and removal of endothelin-1 in human lung, brain, and skeletal muscle.

Authors:  E Weitzberg; G Ahlborg; J M Lundberg
Journal:  Clin Physiol       Date:  1993-11
View more
  8 in total

1.  Proteomic and clinical biomarkers for acute mountain sickness in a longitudinal cohort.

Authors:  Jing Yang; Zhilong Jia; Xinyu Song; Jinlong Shi; Xiaoreng Wang; Xiaojing Zhao; Kunlun He
Journal:  Commun Biol       Date:  2022-06-06

2.  Pulmonary Embolism Masquerading as High Altitude Pulmonary Edema at High Altitude.

Authors:  Prativa Pandey; Benu Lohani; Holly Murphy
Journal:  High Alt Med Biol       Date:  2016-10-21       Impact factor: 1.981

3.  Association between genetic polymorphism of telomere-associated gene ACYP2 and the risk of HAPE among the Chinese Han population: A Case-control study.

Authors:  Linhao Zhu; Lijun Liu; Xue He; Mengdan Yan; Jieli Du; Hua Yang; Yuan Zhang; Dongya Yuan; Tianbo Jin
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

4.  Effect of mountain ultra-marathon running on plasma angiopoietin-like protein 4 and lipid profile in healthy trained men.

Authors:  Monika Górecka; Krzysztof Krzemiński; Monika Buraczewska; Agnieszka Kozacz; Jan Dąbrowski; Andrzej Wojciech Ziemba
Journal:  Eur J Appl Physiol       Date:  2019-11-09       Impact factor: 3.078

Review 5.  Vascular homeostasis at high-altitude: role of genetic variants and transcription factors.

Authors:  Neha Chanana; Tsering Palmo; John H Newman; M A Qadar Pasha
Journal:  Pulm Circ       Date:  2020-11-19       Impact factor: 3.017

6.  Relaxin does not prevent development of hypoxia-induced pulmonary edema in rats.

Authors:  Ute Kowalleck; Mohamed A Abdalla Ahmed; Julia Koedel; Katrin Schierle; Aida Salameh; Beate Rassler
Journal:  Pflugers Arch       Date:  2022-07-02       Impact factor: 4.458

7.  The EDN1 Missense Variant rs5370G > T Regulates Adaptation and Maladaptation under Hypobaric Hypoxia.

Authors:  Tsering Palmo; Bilal Ahmed Abbasi; Neha Chanana; Kavita Sharma; Mohammed Faruq; Tashi Thinlas; Malik Z Abdin; Qadar Pasha
Journal:  Int J Environ Res Public Health       Date:  2022-09-06       Impact factor: 4.614

8.  The Influence of CO2 and Exercise on Hypobaric Hypoxia Induced Pulmonary Edema in Rats.

Authors:  Ryan L Sheppard; Joshua M Swift; Aaron Hall; Richard T Mahon
Journal:  Front Physiol       Date:  2018-02-28       Impact factor: 4.566

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.